ArticleBMC infectious diseases2025
Performance of Xpert MTB/RIF and acid-fast bacilli smear microscopy for the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage samples in negative or sputum-scarce adults in Colombia: a retrospective diagnostic accuracy study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of Xpert MTB/RIF Ultra performance on bronchoalveolar lavage fluid samples for pulmonary tuberculosis diagnosis.Respiratory research & clinical practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited literature exists on the diagnostic yield of traditional and molecular tuberculosis (TB) tests using bronchoalveolar lavage (BAL) specimens in high burden South American countries. The aim of the study is to determine the value of acid-fast bacilli (AFB) smear microscopy and Xpert MTB/RIF using BAL samples for diagnosing pulmonary TB (PTB) in negative or sputum-scarce adults.
methodsA cross-sectional, retrospective diagnostic accuracy study was carried out between January 1, 2015 and December 31, 2023. Demographic, clinical, imaging and microbiologic data were collected from consecutive medical records of initially negative or sputum-scarce adults, who underwent bronchoscopy due to presumptive PTB. Positive cultures were identified as Mycobacterium tuberculosis. Validity criteria was evaluated by sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and Cohen's kappa with their 95% confidence intervals using Wilson's score method by OpenEpi Version 3.01.
resultsOf the 701 medical records screened, 283 adults were included. Cough (89.59%) and fever (64.31%) were the most frequent symptoms. Smear microscopy obtained a sensitivity of 39.22% (95% CI 27.03-52.92), specificity of 98.26% (95% CI 95.61-99.32), PPV of 83.33% (95% CI 64.15-93.32), NPV of 87.94% (95% CI 83.39-91.37) and Cohen's kappa of 0.472 (95% CI 0.3652-0.5788). Xpert MTB/RIF obtained a sensitivity of 91.67% (95% CI 80.45-96.71), specificity of 90.09% (95% CI 85.33-93.43), PPV of 67.69% (95% CI 55.61-77.8), NPV of 97.95% (95% CI 94.85-99.2) and Cohen's kappa of 0.7191 (95% CI 0.5998-0.8384).
conclusionsXpert MTB/RIF outperformed smear microscopy using BAL samples for the diagnosis of PTB in negative or sputum-scarce adults from a high burden Colombian setting. Due to rapid results, affordability and accessibility, particularly in resource-limited settings, smear microscopy should still be considered for BAL samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.